Startseite ProdukteMedizinische Testmaterialien

Dengue Fever Combo Rapid Test Dual-Window Cassette for Early and Past Infection Detection with 15-Minute Results

Bescheinigung
China Sichuan Hundred Medcal Technology Co., Ltd. zertifizierungen
China Sichuan Hundred Medcal Technology Co., Ltd. zertifizierungen
Ich bin online Chat Jetzt

Dengue Fever Combo Rapid Test Dual-Window Cassette for Early and Past Infection Detection with 15-Minute Results

Dengue Fever Combo Rapid Test Dual-Window Cassette for Early and Past Infection Detection with 15-Minute Results
Dengue Fever Combo Rapid Test Dual-Window Cassette for Early and Past Infection Detection with 15-Minute Results Dengue Fever Combo Rapid Test Dual-Window Cassette for Early and Past Infection Detection with 15-Minute Results

Großes Bild :  Dengue Fever Combo Rapid Test Dual-Window Cassette for Early and Past Infection Detection with 15-Minute Results

Produktdetails:
Herkunftsort: China
Markenname: HDRMEDICO
Zertifizierung: CE
Modellnummer: /
Zahlung und Versand AGB:
Min Bestellmenge: 500 Stück
Preis: Verhandelbar
Verpackung Informationen: Karton
Lieferzeit: 10-15 Tage
Zahlungsbedingungen: L/C, T/T, Westenunion, Geld Gramm, Paypal/VTB
Versorgungsmaterial-Fähigkeit: 100000PC/Monat
Kontakt Plaudern Sie Jetzt

Dengue Fever Combo Rapid Test Dual-Window Cassette for Early and Past Infection Detection with 15-Minute Results

Beschreibung
Produktname: Dengue-Fieber-Kombi-Schnelltest (NS1+IgG/IgM), Doppelfenster-Kassette Material: Plastik
Produktkategorie: In vitro-Diagnose Testdauer: 15 Minuten
Haltbarkeit: Zwei Jahre Funktion: Erkennung von Infektionskrankheiten
Hervorheben:

15-minute test duration Dengue Fever Combo Rapid Test

,

Early and past infection detection Dual-Window Cassette

,

Colloidal gold immunochromatographic assay NS1+IgG/IgM Test

Dengue Fever Combo Rapid Test (NS1+IgG/IgM) Dual-Window Cassette
Product Overview

This rapid diagnostic test utilizes colloidal gold immunochromatographic technology for simultaneous detection of dengue virus markers in human serum, plasma, or whole blood. The dual-window design provides comprehensive testing for both early and past infections.

Detection Targets & Clinical Significance
Window 1: Dengue Virus NS1 Antigen

Detects the NS1 protein produced by the dengue virus during the acute phase of infection (typically days 1-7 of fever). A positive NS1 result indicates active, current dengue infection, enabling early diagnosis.

Window 2: Anti-Dengue Antibodies (IgG & IgM)

Identifies specific immune response antibodies:

  • IgM: Appears early after symptom onset
  • IgG: Develops later and provides lifelong immunity
The IgG/IgM pattern helps determine infection phase and immune status, crucial for clinical management.

Key Advantages
  • Comprehensive Detection: Combined NS1 and antibody testing extends the diagnostic window from first day of symptoms
  • Differential Diagnosis: Distinguishes dengue from similar febrile illnesses (chikungunya, Zika, malaria)
  • Rapid Results: Visual results within 15-20 minutes with minimal equipment requirements
  • Clinical Risk Assessment: Antibody profile identifies infection history and severe dengue risk factors
  • Point-of-Care Ready: Ideal for clinical settings, hospitals, and resource-limited environments
Result Interpretation
Window Positive Result Indication
Window 1 (NS1) Control line (C) + Test line (T) = Active dengue infection
Window 2 (Ab) Control line (C) + IgM and/or IgG lines = Specific antibody response pattern indicating infection stage
Interpret specific line combinations according to manufacturer instructions to determine primary or secondary infection status.
Clinical Applications

This test supports WHO recommendations for improved dengue diagnosis by enabling early detection, timely supportive care, monitoring of high-risk patients, and effective public health surveillance in dengue-endemic regions.

Kontaktdaten
Sichuan Hundred Medcal Technology Co., Ltd.

Ansprechpartner: Mr. Terry

Telefon: 15008220675

Senden Sie Ihre Anfrage direkt an uns (0 / 3000)